计算溶液所需的质量、体积或浓度。
BI-2545 is a potent autotaxin (ATX) inhibitor that significantly reduces LPA, with IC 50 s of 2.2 nM and 3.4 nM for human ATX and rat ATX, respectively
In Vitro
BI-2545 displays good potency in the LPA and rat whole blood assay with IC 50 s of 29 nM and 96 nM, respectively. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
BI-2545 (10 mg/kg; p.o.) has high and sustained in vivo efficacy in reducing LPAs . BI-2545 (10 mg/kg; p.o.) has a half-life of t 1/2 =3.4 hours . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Rat Dosage: 10 mg/kg Administration: Oral administration Result: Reduces the sum of the plasma LPA species up to 90%.
IC50& Target:C50: 2.2 nM (human ATX), 3.4 nM (rat ATX)